S, S., C, P., M, L., F, L. A., SP, M., & G, B. (2025). Infographic: Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial. Eye (London, England). https://doi.org/10.1038/s41433-025-03991-z
Chicago Style (17th ed.) CitationS, Sherratt-Mayhew, Page C, Lowe M, Labella Alvarez F, Mollan SP, and Berman G. "Infographic: Therapeutic Benefit of Idebenone in Patients with Leber Hereditary Optic Neuropathy: The LEROS Nonrandomized Controlled Trial." Eye (London, England) 2025. https://doi.org/10.1038/s41433-025-03991-z.
MLA (9th ed.) CitationS, Sherratt-Mayhew, et al. "Infographic: Therapeutic Benefit of Idebenone in Patients with Leber Hereditary Optic Neuropathy: The LEROS Nonrandomized Controlled Trial." Eye (London, England), 2025, https://doi.org/10.1038/s41433-025-03991-z.